BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24125889)

  • 1. Novel cancer-targeting SPECT/NIRF dual-modality imaging probe (99m)Tc-PC-1007: synthesis and biological evaluation.
    Zhang Y; Xiao L; Popovic K; Xie X; Chordia MD; Chung LW; Williams MB; Yue W; Pan D
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6350-4. PubMed ID: 24125889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Radioimmune
    Ye M; Gai Y; Ji H; Jiang Y; Qiao P; Wang W; Zhang Y; Xia X; Lan X
    Front Immunol; 2021; 12():660842. PubMed ID: 34484174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Biological Evaluation of Novel
    Song X; Gan Q; Zhang X; Zhang J
    Mol Pharm; 2019 Oct; 16(10):4213-4222. PubMed ID: 31424939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
    Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
    Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and
    Okarvi SM; Aljammaz I
    Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heptamethine cyanine based (64)Cu-PET probe PC-1001 for cancer imaging: synthesis and in vivo evaluation.
    Xiao L; Zhang Y; Yue W; Xie X; Wang JP; Chordia MD; Chung LW; Pan D
    Nucl Med Biol; 2013 Apr; 40(3):351-60. PubMed ID: 23375364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECT/NIRF Dual Modality Imaging for Detection of Intraperitoneal Colon Tumor with an Avidin/Biotin Pretargeting System.
    Dong C; Yang S; Shi J; Zhao H; Zhong L; Liu Z; Jia B; Wang F
    Sci Rep; 2016 Jan; 6():18905. PubMed ID: 26732543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
    Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
    J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With 99mTc-Labeled Duramycin SPECT/CT.
    Luo R; Niu L; Qiu F; Fang W; Fu T; Zhao M; Zhang YJ; Hua ZC; Li XF; Wang F
    Mol Imaging; 2016; 15():. PubMed ID: 27030401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism.
    Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D
    Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.
    Okarvi SM; AlJammaz I
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of
    Saednia S; Emami S; Molavipordanjani S; Abedi SM; Amiri FT; Hosseinimehr SJ
    Mol Pharm; 2021 Jun; 18(6):2360-2374. PubMed ID: 34027660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.
    Han Z; Xiao Y; Wang K; Yan J; Xiao Z; Fang F; Jin Z; Liu Y; Sun X; Shen B
    J Nucl Med; 2018 Nov; 59(11):1686-1691. PubMed ID: 29777004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon cancer.
    Jing B; Gai Y; Qian R; Liu Z; Zhu Z; Gao Y; Lan X; An R
    J Nanobiotechnology; 2021 Jan; 19(1):7. PubMed ID: 33407513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of
    Zhang X; Hu F; Liu C; Yin L; Zhang Y; Zhang Y; Lan X
    Contrast Media Mol Imaging; 2018; 2018():7832805. PubMed ID: 29853809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.
    Zhang C; Zhao Y; Zhao N; Tan D; Zhang H; Chen X; Zhang H; An J; Shi C; Li M
    Contrast Media Mol Imaging; 2018; 2018():4979746. PubMed ID: 29706843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer
    Shi J; Du S; Wang R; Gao H; Luo Q; Hou G; Zhou Y; Zhu Z; Wang F
    J Transl Med; 2023 Jan; 21(1):19. PubMed ID: 36631812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2-targeted dual radiotracer approach with clinical potential for noninvasive imaging of trastuzumab-resistance caused by epitope masking.
    Li L; Liu T; Shi L; Zhang X; Guo X; Hu B; Yao M; Zhu H; Yang Z; Jia B; Wang F
    Theranostics; 2022; 12(12):5551-5563. PubMed ID: 35910795
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of
    Rainone P; Riva B; Belloli S; Sudati F; Ripamonti M; Verderio P; Colombo M; Colzani B; Gilardi MC; Moresco RM; Prosperi D
    Int J Nanomedicine; 2017; 12():3447-3461. PubMed ID: 28496321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.